Cargando…
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
BACKGROUND: Data on the relative contribution of clinical and neuroimaging risk factors to acute ischemic stroke (AIS) versus intracerebral hemorrhage (ICH) occurring on oral anticoagulant treatment are scarce. METHODS AND RESULTS: Cross‐sectional study was done on consecutive oral anticoagulant–tre...
Autores principales: | Schaub, Fabian, Polymeris, Alexandros A., Schaedelin, Sabine, Hert, Lisa, Meya, Louisa, Thilemann, Sebastian, Traenka, Christopher, Wagner, Benjamin, Seiffge, David, Gensicke, Henrik, De Marchis, Gian Marco, Bonati, Leo, Engelter, Stefan T., Peters, Nils, Lyrer, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075191/ https://www.ncbi.nlm.nih.gov/pubmed/34935409 http://dx.doi.org/10.1161/JAHA.121.023345 |
Ejemplares similares
-
Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation
por: Kubacka, Marta, et al.
Publicado: (2023) -
Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022) -
Acute Ischemic Stroke in Nonconvulsive Status Epilepticus–Underestimated? Results from an Eight-Year Cohort Study
por: Traenka, Christopher, et al.
Publicado: (2017) -
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial
por: Polymeris, Alexandros A., et al.
Publicado: (2023) -
Reasons for Prehospital Delay in Acute Ischemic Stroke
por: Fladt, Joachim, et al.
Publicado: (2019)